$RHHBY News Article - Ad hoc announcement pursuant to Art. 53 LR: Genentech's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer's Disease https://marketwirenews.com/news-releases/ad-h...10452.html